NYSE:DNA | Cash Flow Statement | Ginkgo Bioworks Holdings, Inc.

Complete source-backed cash-flow history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$46.71M
2026-03-31-$82.59M-$46.69M$1.93M$23.13M-$19,000.00
2025-12-31-$80.75M-$47.68M$5,000.00$95.1M$8.14M
2025-09-30-$80.76M
2025-06-30-$60.3M
2025-03-31-$90.96M-$51.52M$7.62M-$198.68M-$207,000.00
2024-12-31-$107.53M-$42.44M$13.71M-$13.09M-$203,000.00
2024-09-30-$56.4M
2024-06-30-$217.18M
2024-03-31-$165.91M-$89.26M$6.71M-$12.11M-$845,000.00
2023-12-31-$211.69M-$57.83M$3.45M-$46.67M-$632,000.00
2023-09-30-$302.89M
2023-06-30-$173.32M
2023-03-31-$204.97M-$90.59M$19.44M-$19.41M-$888,000.00
2022-12-31-$175.47M-$104.53M$25.65M$29.74M$97.76M
2022-09-30-$670.13M
2022-06-30-$668.83M
2022-03-31-$590.51M-$19.9M$3.58M-$35.99M-$1.19M
2021-12-31-$1.6B-$165.54M$5.11M$4.23M-$11.04M
2021-09-30-$101.88M
2021-06-30-$53.94M
2021-03-31-$73.57M-$48.13M$21.94M-$23.05M-$433,000.00
2020-12-31-$46.92M-$59.34M$19.41M-$28.83M-$186,000.00
2020-09-30-$26.06M
2020-06-30-$28.73M
2020-03-31-$25.47M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$312.76M-$171.06M$7.67M-$240.29M$17.78M
2024-12-31-$547.03M-$319.59M$62.54M-$62.24M-$1.74M
2023-12-31-$892.87M-$295.5M$40.8M-$80.69M-$3.22M
2022-12-31-$2.1B-$252.2M$52.27M-$67.39M$95.34M
2021-12-31-$1.83B-$253.82M$56.52M-$73.26M$1.53B
2020-12-31-$126.61M-$135.83M$57.82M-$67.12M$90.32M
2019-12-31-$119.33M-$44.66M$22.22M-$74.6M$408,000.00$410.39M